LAWLIS V BRYAN

Director at ARADIGM CORP · on record since Apr 13, 2006
President at ARADIGM CORP · on record since Apr 13, 2006
Director at BIOMARIN PHARMACEUTICAL INC · on record since Jun 21, 2007
Director at GERON CORP · on record since Mar 15, 2012
Director at HUMANIGEN, INC · on record since Aug 15, 2013
Director at Coherus Oncology, Inc. · on record since Nov 12, 2014
Director at SUTRO BIOPHARMA, INC. · on record since Sep 27, 2018
Director at Spyre Therapeutics, Inc. · on record since Jul 17, 2018

Insider trading activity of LAWLIS V BRYAN

Transactions on record: 150; since Mar 4, 2004

Open-market buys: 1; $15.7K

Open-market sells: 32; $11.2M

Companies traded: 7; last filing May 22, 2025

Figures computed from official regulatory filings — .

Companies where LAWLIS V BRYAN has traded

GERON CORP21 tx · $358.3K · May 22, 2025
BIOMARIN PHARMACEUTICAL INC107 tx · $14.2M · May 24, 2023
Spyre Therapeutics, Inc.5 tx · Jun 9, 2022
Coherus Oncology, Inc.11 tx · Jan 13, 2021
SUTRO BIOPHARMA, INC.1 tx · Sep 27, 2018
HUMANIGEN, INC2 tx · Jun 20, 2014
ARADIGM CORP3 tx · Apr 13, 2006

Track record of LAWLIS V BRYAN

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of LAWLIS V BRYAN

Co-insiders of LAWLIS V BRYAN

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
GERON CORPListing on record	May 22, 2025	AwardD (derivative)	180,000	0.00 USD	—	SEC
GERON CORPListing on record	May 13, 2025	Buy	13,300	1.18 USD	$15.7K	SEC
GERON CORPListing on record	May 17, 2024	ExerciseD (derivative)	-35,000	0.00 USD	—	SEC
GERON CORPListing on record	May 17, 2024	Sell	-35,000	3.75 USD	$131.3K	SEC
GERON CORPListing on record	May 17, 2024	Exercise	35,000	1.94 USD	$67.9K	SEC
GERON CORPListing on record	May 10, 2024	AwardD (derivative)	180,000	0.00 USD	—	SEC
GERON CORPListing on record	Jun 2, 2023	AwardD (derivative)	125,000	0.00 USD	—	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	May 24, 2023	Award	4,190	0.00 USD	—	SEC
GERON CORPListing on record	May 11, 2023	Sell	-35,000	3.00 USD	$105K	SEC
GERON CORPListing on record	May 11, 2023	Exercise	35,000	1.10 USD	$38.5K	SEC
GERON CORPListing on record	May 11, 2023	ExerciseD (derivative)	-35,000	0.00 USD	—	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Apr 4, 2023	Sell	-8,500	97.09 USD	$825.3K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Apr 4, 2023	ExerciseD (derivative)	-8,500	0.00 USD	—	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Apr 4, 2023	Exercise	8,500	67.81 USD	$576.4K	SEC
Spyre Therapeutics, Inc.Listing on record	Jun 9, 2022	AwardD (derivative)	43,000	0.00 USD	—	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	May 26, 2022	Award	4,980	0.00 USD	—	SEC
GERON CORPListing on record	May 11, 2022	AwardD (derivative)	125,000	0.00 USD	—	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Apr 18, 2022	Sell	-4,250	83.66 USD	$355.6K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Apr 18, 2022	ExerciseD (derivative)	-4,250	0.00 USD	—	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Apr 18, 2022	Exercise	4,250	37.46 USD	$159.2K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Jan 19, 2022	Exercise	4,250	37.46 USD	$159.2K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Jan 19, 2022	Sell	-4,250	87.61 USD	$372.3K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Jan 19, 2022	ExerciseD (derivative)	-4,250	0.00 USD	—	SEC
Spyre Therapeutics, Inc.Listing on record	Jun 9, 2021	AwardD (derivative)	40,000	0.00 USD	—	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	May 27, 2021	Award	5,120	0.00 USD	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
GERON CORPListing on record	May 22, 2025	AwardD (derivative)	180,000	0.00 USD	—	SEC
GERON CORPListing on record	May 13, 2025	Buy	13,300	1.18 USD	$15.7K	SEC
GERON CORPListing on record	May 17, 2024	ExerciseD (derivative)	-35,000	0.00 USD	—	SEC
GERON CORPListing on record	May 17, 2024	Sell	-35,000	3.75 USD	$131.3K	SEC
GERON CORPListing on record	May 17, 2024	Exercise	35,000	1.94 USD	$67.9K	SEC
GERON CORPListing on record	May 10, 2024	AwardD (derivative)	180,000	0.00 USD	—	SEC
GERON CORPListing on record	Jun 2, 2023	AwardD (derivative)	125,000	0.00 USD	—	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	May 24, 2023	Award	4,190	0.00 USD	—	SEC
GERON CORPListing on record	May 11, 2023	Sell	-35,000	3.00 USD	$105K	SEC
GERON CORPListing on record	May 11, 2023	Exercise	35,000	1.10 USD	$38.5K	SEC
GERON CORPListing on record	May 11, 2023	ExerciseD (derivative)	-35,000	0.00 USD	—	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Apr 4, 2023	Sell	-8,500	97.09 USD	$825.3K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Apr 4, 2023	ExerciseD (derivative)	-8,500	0.00 USD	—	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Apr 4, 2023	Exercise	8,500	67.81 USD	$576.4K	SEC
Spyre Therapeutics, Inc.Listing on record	Jun 9, 2022	AwardD (derivative)	43,000	0.00 USD	—	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	May 26, 2022	Award	4,980	0.00 USD	—	SEC
GERON CORPListing on record	May 11, 2022	AwardD (derivative)	125,000	0.00 USD	—	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Apr 18, 2022	Sell	-4,250	83.66 USD	$355.6K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Apr 18, 2022	ExerciseD (derivative)	-4,250	0.00 USD	—	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Apr 18, 2022	Exercise	4,250	37.46 USD	$159.2K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Jan 19, 2022	Exercise	4,250	37.46 USD	$159.2K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Jan 19, 2022	Sell	-4,250	87.61 USD	$372.3K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Jan 19, 2022	ExerciseD (derivative)	-4,250	0.00 USD	—	SEC
Spyre Therapeutics, Inc.Listing on record	Jun 9, 2021	AwardD (derivative)	40,000	0.00 USD	—	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	May 27, 2021	Award	5,120	0.00 USD	—	SEC